NEW YORK – The European Commission on Monday approved Johnson & Johnson's subcutaneous Rybrevant (amivantamab) in two new dosing schedules as a first-line treatment for patients with advanced ...
Approval in adults and children aged 6 years and older supported by Phase 3 trial demonstrating Dupixent significantly reduced nasal signs and ...
ZME Science on MSN
New Injectable Therapy Helped Paralyzed Mice Walk and It Just Passed a Major Test on Human Cells
In a petri dish at Northwestern University, researchers grow organoids modeled on the human spinal cord: simplified, lab-made ...
This potentially useful study reports a new method for restoring sperm motility. Strengths are in the methodology being developed, but the conclusions require additional experimental support. The ...
Many people living with rheumatoid arthritis (RA) rely on long-term medications to manage joint pain, stiffness, and inflammation. A number of these treatments are given as subcutaneous injections, ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Subcutaneous anifrolumab improved over placebo in BICLA ...
The U.S. Food and Drug Administration (FDA) is reviewing an application seeking expanded approval of an under-the-skin injection version of Leqembi (lecanemab), called Leqembi Iqlik. Leqembi is an ...
GLP-1 medications, such as Ozempic and Wegovy, are injected into the fatty layer beneath the skin to manage blood sugar and aid in weight management. The recommended injection sites include the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results